The Familial Breast Cancer Research Unit at Women’s College Hospital is conducting a research study to better understand breast cancer treatment among people with PALB2, ATM and CHEK2 gene mutations.
Research shows that mutations in PALB2, ATM, and CHEK2 increase the risk of developing breast cancer. However, it remains unclear how to best treat or reduce the risk of breast cancer in women with these mutations. Gaining more knowledge about breast cancer in patients with PALB2, ATM, or CHEK2 mutations will help to better understand:
- The most effective treatment for individuals with a PALB2, ATM, or CHEK2 mutation and breast cancer to increase survival chances
- Whether patients with PALB2-, ATM-, or CHEK2-associated breast cancer are at increased risk of developing a new breast cancer
- The best strategies for managing cancer risks in healthy family members who carry a PALB2, ATM, or CHEK2 mutation (through screening, preventive surgery, etc.)
By gaining a better understanding of hereditary breast cancer, we can personalize treatment to improve survival rates and identify the best strategies for managing at-risk family members, helping to detect cancer early or prevent it.
How to get more information:
If you are interested in participating or would like to learn more about the Treatment Study, please:
- Complete a self-referral form here.
- Email the study team at TreatmentStudy@wchospital.ca
- Call the study coordinator at 416-323-6400, ext. 2749 or 5125